Ralph J. Gitomer

Array ( [id] => 7421861 [patent_doc_number] => 20040229237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Mast cell-specific signal transducer and cDNA thereof' [patent_app_type] => new [patent_app_number] => 10/717619 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3495 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229237.pdf [firstpage_image] =>[orig_patent_app_number] => 10717619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7410839 [patent_doc_number] => 20040106538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Regulators of PPARdelta (beta) and their use in the treatment of obesity and insulin resistance' [patent_app_type] => new [patent_app_number] => 10/718470 [patent_app_country] => US [patent_app_date] => 2003-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6800 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106538.pdf [firstpage_image] =>[orig_patent_app_number] => 10718470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089734 [patent_doc_number] => 20050009847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Compounds and methods for increasing neurogenesis' [patent_app_type] => utility [patent_app_number] => 10/718071 [patent_app_country] => US [patent_app_date] => 2003-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28113 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009847.pdf [firstpage_image] =>[orig_patent_app_number] => 10718071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 359743 [patent_doc_number] => 07485622 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-03 [patent_title] => 'Paralytic peptide for use in neuromuscular therapy' [patent_app_type] => utility [patent_app_number] => 10/716314 [patent_app_country] => US [patent_app_date] => 2003-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 9809 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/485/07485622.pdf [firstpage_image] =>[orig_patent_app_number] => 10716314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7288016 [patent_doc_number] => 20040147442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Thrombin-inhibiting peptides' [patent_app_type] => new [patent_app_number] => 10/694847 [patent_app_country] => US [patent_app_date] => 2003-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3211 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147442.pdf [firstpage_image] =>[orig_patent_app_number] => 10694847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5794252 [patent_doc_number] => 20060014933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Using amines or amino acids as mobile phase modifiers in chromatography' [patent_app_type] => utility [patent_app_number] => 10/526301 [patent_app_country] => US [patent_app_date] => 2003-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5381 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014933.pdf [firstpage_image] =>[orig_patent_app_number] => 10526301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034513 [patent_doc_number] => 20050033023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'PTH-rP related peptide cancer therapeutics' [patent_app_type] => utility [patent_app_number] => 10/691125 [patent_app_country] => US [patent_app_date] => 2003-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 25869 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20050033023.pdf [firstpage_image] =>[orig_patent_app_number] => 10691125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 570542 [patent_doc_number] => 07459169 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-02 [patent_title] => 'Surface coating comprising bioactive compound' [patent_app_type] => utility [patent_app_number] => 10/689869 [patent_app_country] => US [patent_app_date] => 2003-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11272 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/459/07459169.pdf [firstpage_image] =>[orig_patent_app_number] => 10689869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7280809 [patent_doc_number] => 20040063186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Vectors and methods for recombinant protein expression' [patent_app_type] => new [patent_app_number] => 10/683775 [patent_app_country] => US [patent_app_date] => 2003-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8112 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063186.pdf [firstpage_image] =>[orig_patent_app_number] => 10683775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 813753 [patent_doc_number] => 07414026 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-19 [patent_title] => 'Inhibitors of NF-kappaB activation' [patent_app_type] => utility [patent_app_number] => 10/680998 [patent_app_country] => US [patent_app_date] => 2003-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 10977 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/414/07414026.pdf [firstpage_image] =>[orig_patent_app_number] => 10680998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 428682 [patent_doc_number] => 07268116 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-11 [patent_title] => 'Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins' [patent_app_type] => utility [patent_app_number] => 10/677877 [patent_app_country] => US [patent_app_date] => 2003-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 7508 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/268/07268116.pdf [firstpage_image] =>[orig_patent_app_number] => 10677877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7463461 [patent_doc_number] => 20040101478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'In vivo methods of determining activity of receptor-type kinase inhibitors' [patent_app_type] => new [patent_app_number] => 10/473513 [patent_app_country] => US [patent_app_date] => 2003-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7513 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101478.pdf [firstpage_image] =>[orig_patent_app_number] => 10473513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7353315 [patent_doc_number] => 20040249133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Use of lipopeptides or lipoproteins for treating lung infections and lung tumours' [patent_app_type] => new [patent_app_number] => 10/398094 [patent_app_country] => US [patent_app_date] => 2003-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1193 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20040249133.pdf [firstpage_image] =>[orig_patent_app_number] => 10398094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 519978 [patent_doc_number] => 07189811 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-13 [patent_title] => 'Process for solubilization of recombinant proteins expressed as inclusion body' [patent_app_type] => utility [patent_app_number] => 10/655664 [patent_app_country] => US [patent_app_date] => 2003-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 5475 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/189/07189811.pdf [firstpage_image] =>[orig_patent_app_number] => 10655664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5648395 [patent_doc_number] => 20060134127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Antiallergic agent' [patent_app_type] => utility [patent_app_number] => 10/525567 [patent_app_country] => US [patent_app_date] => 2003-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12623 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134127.pdf [firstpage_image] =>[orig_patent_app_number] => 10525567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7010714 [patent_doc_number] => 20050064430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Rabconnectin-3-binding protein' [patent_app_type] => utility [patent_app_number] => 10/645335 [patent_app_country] => US [patent_app_date] => 2003-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16082 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20050064430.pdf [firstpage_image] =>[orig_patent_app_number] => 10645335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7168786 [patent_doc_number] => 20040077542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Apoptotic compounds' [patent_app_type] => new [patent_app_number] => 10/641539 [patent_app_country] => US [patent_app_date] => 2003-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14245 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077542.pdf [firstpage_image] =>[orig_patent_app_number] => 10641539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7026506 [patent_doc_number] => 20050020506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Crosslinked compositions comprising collagen and demineralized bone matrix, methods of making and methods of use' [patent_app_type] => utility [patent_app_number] => 10/626571 [patent_app_country] => US [patent_app_date] => 2003-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4569 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020506.pdf [firstpage_image] =>[orig_patent_app_number] => 10626571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5777302 [patent_doc_number] => 20060105942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Inhibition of cell division based use of analogs of neuropeptide y' [patent_app_type] => utility [patent_app_number] => 10/521974 [patent_app_country] => US [patent_app_date] => 2003-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5847 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20060105942.pdf [firstpage_image] =>[orig_patent_app_number] => 10521974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6982830 [patent_doc_number] => 20050152900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Compositions and methods for apo-b48 and apo-b100 assay' [patent_app_type] => utility [patent_app_number] => 10/513916 [patent_app_country] => US [patent_app_date] => 2003-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7283 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20050152900.pdf [firstpage_image] =>[orig_patent_app_number] => 10513916 [rel_patent_id] =>[rel_patent_doc_number] =>)